Skip to main content

5 articles related to "Mir 503"

No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.

Articles

Original Research

Published on 23 May 2023

Diabetic macrophage small extracellular vesicles-associated miR-503/IGF1R axis regulates endothelial cell function and affects wound healing

in Inflammation

Jianqiang Wang
Yuanshan Han
Fang Huang
Liuhuan Tang
Jianfei Mu
Ying Liang

Frontiers in Immunology

doi 10.3389/fimmu.2023.1104890

6,425 views
28 citations

Review

Published on 08 Mar 2021

The Causes and Consequences of miR-503 Dysregulation and Its Impact on Cardiovascular Disease and Cancer

in Experimental Pharmacology and Drug Discovery

Yanjing He
Yin Cai
Pearl Mingchu Pai
Xinling Ren
Zhengyuan Xia

Frontiers in Pharmacology

doi 10.3389/fphar.2021.629611

6,694 views
26 citations

Original Research

Published on 15 Aug 2014

Microparticles Mediate the Intercellular Regulation of microRNA-503 and Proline-Rich Tyrosine Kinase 2 to Alter the Migration and Invasion Capacity of Breast Cancer Cells

in Molecular and Cellular Oncology

Joyce Gong
Frederick Luk
Ritu Jaiswal
Mary Bebawy

Frontiers in Oncology

doi 10.3389/fonc.2014.00220

6,867 views
37 citations

Systematic Review

Published on 14 Feb 2023

Meta-analysis of the characteristic expression of circulating microRNA in type 2 diabetes mellitus with acute ischemic cerebrovascular disease

in Clinical Diabetes

Feifei Hu
Lei Liu
Zhijian Liu
Mingfeng Cao
Guanghong Li
Xinhuan Zhang

Frontiers in Endocrinology

doi 10.3389/fendo.2023.1129860

3,935 views
6 citations

Original Research

Published on 12 Sep 2025

Icaritin inhibits osteoclast differentiation and reduces bone loss by targeting ESR1 to inhibit miR503/RANK pathway

in Experimental Pharmacology and Drug Discovery

Baoping Xie
Xiaofei Liao
Liuyan Xin
Zhen Xie
Qi Jin
An Li
Hongliang Li
Jinping Li

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1603333

2,252 views